Evaluation of anti-tumour properties of two depsidones – Unguinol and Aspergillusidone D – in triple-negative MDA-MB-231 breast tumour cells. Zwartsen, A., Chottanapund, S., Kittakoop, P., Navasumrit, P., Ruchirawat, M., Van Duursen, M. B. M. and Van den Berg, M. (2019). Toxicology Reports, 6, 1216-1222.

28 Dec 2019
0
0

Evaluation of anti-tumour properties of two depsidones – Unguinol and Aspergillusidone D – in triple-negative MDA-MB-231 breast tumour cells. Zwartsen, A., Chottanapund, S., Kittakoop, P., Navasumrit, P., Ruchirawat, M., Van Duursen, M. B. M. and Van den Berg, M. (2019). Toxicology Reports, 6, 1216-1222.

Tags

Share this

Related Posts

Method for sample preparation of cell suspension for dielectrophoresis-based toxicity testing. [in Thai] Thailand patent number: 67559 Registered on January 18, 2019 More information can be found at http://patentsearch.ipthailand.go.th/DIP2013/view_public_data.php?appno=98805
18 Jan 2019
0

Method for sample preparation of cell suspension for dielectrophoresis-based toxicity testing. [in Thai] Thailand patent number: 67559 Registered on January 18, 2019 More information can be found at http://patentsearch.ipthailand.go.th/DIP2013/view_public_data.php?appno=98805

Method for sample preparation of cellsuspension for dielectrophoresis-based toxicity testing. [in Thai] Thailand patent number: 67559 Registered on January 18, 2019 More information can be found athttp://patentsearch.ipthailand.go.th/DIP2013/view_public_data.php?appno=98805
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More